Legal DealFolio - Catalyst Health Solutions, Inc. Acquisition Financing

Davis Polk is advising Goldman Sachs Lending Partners LLC, Citigroup Global Markets Inc., SunTrust Robinson Humphrey, Inc. and Wells Fargo Securities, LLC as joint lead arrangers in connection with a $700 million back-stop acquisition facility, including a $500 million senior secured term loan facility and $200 million senior secured revolving facility, for Catalyst Health Solutions, Inc. in connection with its acquisition of Walgreens Health Initiatives, Inc., a wholly owned subsidiary of Walgreen Co. Catalyst Health Solutions, Inc. is a leading full-service PBM company in the United States, operating primarily under the brand name Catalyst Rx. Its clients include self-insured employers, including state and local governments, managed care organizations, unions, third-party administrators, hospices and individuals seeking the prescription drug component of their overall health benefit programs. Catalyst Health Solutions, Inc. is a publicly traded company on the Nasdaq Stock Market. According to Catalyst, the acquisition would increase its PBM membership to more than 18 million members from about 7 million. The Davis Polk team includes partner James A. Florack and associates Peter T. Bazos and Cristina del Rivero (not yet admitted). All members of the Davis Polk team are based in the New York office.

Deal Date:	11-03-2011	Practice Area:	International Finance and Bank Credit
Deal Title:	Catalyst Health Solutions, Inc. Acquisition Financing	Industry:	Healthcare Equipment & Services
Description:	Davis Polk is advising Goldman Sachs Lending Partners LLC, Citigroup Global Markets Inc., SunTrust Robinson Humphrey, Inc. and Wells Fargo Securities, LLC as joint lead arrangers in connection with a $700 million back-stop acquisition facility, including a $500 million senior secured term loan facility and $200 million senior secured revolving facility, for Catalyst Health Solutions, Inc. in connection with its acquisition of Walgreens Health Initiatives, Inc., a wholly owned subsidiary of Walgreen Co. Catalyst Health Solutions, Inc. is a leading full-service PBM company in the United States, operating primarily under the brand name Catalyst Rx. Its clients include self-insured employers, including state and local governments, managed care organizations, unions, third-party administrators, hospices and individuals seeking the prescription drug component of their overall health benefit programs. Catalyst Health Solutions, Inc. is a publicly traded company on the Nasdaq Stock Market. According to Catalyst, the acquisition would increase its PBM membership to more than 18 million members from about 7 million. The Davis Polk team includes partner James A. Florack and associates Peter T. Bazos and Cristina del Rivero (not yet admitted). All members of the Davis Polk team are based in the New York office.
Financial Center:	New York	Value:	0.00-100.00
Advised Party:	Lender	Law Firm	Davis Polk
Borrower Jurisdiction:	United States	Lender Jurisdiction:	United States
Classification:	Acquisition Finance Private Company Acquisition	Lawyer	James A Florack

Practice Areas -

International Finance and Bank Credit Law Firms and Lawyers

Practice Areas - International Finance and Bank Credit Law Firms and Lawyers